Vidaza Side Effects
Recent Questions and Answers about Vidaza
Is 'azacytidine' sold as medicine for cancer treatment?
View Community-reported Vidaza side effects
Add Your Side Effect to the Community Database
Help Community - Describe Your Vidaza Side Effect
Have You dealt with a Vidaza side effect? Share your experience
Vidaza Side Effects summary
Total Vidaza reports: 67.Vidaza FDA safety alerts: No.
Reported deaths: 20 Reported hospitalizations: 53.
Take Vidaza Side Effects Survey, Discuss Vidaza with others
Vidaza Side Effects: nausea, pneumonia, hypotension, asthenia, anaemia, pancytopenia, condition aggravated, bacterial infection, vomiting, febrile neutropenia, diarrhoea,
Vidaza Usage.
If you have questions about Vidaza, you can ask a Health Expert or Ask Patient Community about Vidaza.
Vidaza Side Effects reported to FDA
Showing 1-40 of 67 Next >
Vidaza Side Effects Report #5402040-2Physician from FRANCE reported VIDAZA problem on July 12, 2007. Male patient, 55 years of age, weighting 220.5 lb, was diagnosed with myelodysplastic syndrome, thrombosis prophylaxis, pyrexia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: bacterial infection, catheter related infection, culture urine positive, escherichia infection, international normalised ratio increased, pneumonia klebsiella, sepsis. VIDAZA dosage: 120 MG (DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with PREVISCAN, AMOXICILLIN, ATENOLOL. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5380511-5
VIDAZA problem was reported by a Physician from UNITED KINGDOM on June 21, 2007. Male patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: anaemia, nausea, polychromasia, red blood cell spherocytes present. VIDAZA dosage: 75 MG/M2 (DAILY X 5 DAYS),INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE, ACYCLOVIR. Patient recovered.
Vidaza Side Effects Report #5385214-9
Physician from UNITED KINGDOM reported VIDAZA problem on June 22, 2007. Male patient, 68 years of age, weighting 154.3 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: abscess intestinal. VIDAZA dosage: (75 MG/M2, SUBCUTANEOUS. During the same period patient was treated with CIPROFLOXACIN, NYSTATIN, ACYCLOVIR. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5397276-3
VIDAZA problem was reported by a Physician from GERMANY on July 09, 2007. Male patient, 55 years of age, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia, prophylaxis of nausea and vomiting and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: aggression. VIDAZA dosage: 75 MG/M2 (DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with ONDANSETRON. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5398952-9
Pharmacist from UNITED STATES reported VIDAZA problem on July 24, 2007. Female patient, 81 years of age, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: pancytopenia. VIDAZA dosage: unknown. During the same period patient was treated with TYLENOL, HEPARIN, AZTREONAM, CIPROFLOXACIN, ALBUTEROL, IPRATROPIUM BROMIDE, BACTRIM, VANCOMYCIN. Patient was hospitalized. Patient died on 04/04/2006.
Vidaza Side Effects Report #5402040-2
VIDAZA problem was reported by a Physician from FRANCE on July 12, 2007. Male patient, 55 years of age, weighting 220.5 lb, was diagnosed with myelodysplastic syndrome, thrombosis prophylaxis, pyrexia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: bacterial infection, catheter related infection, culture urine positive, escherichia infection, international normalised ratio increased, pneumonia klebsiella, sepsis. VIDAZA dosage: 120 MG (DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with PREVISCAN, AMOXICILLIN, ATENOLOL. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5760654-4
Physician from UNITED STATES reported VIDAZA problem on May 23, 2008. Female patient, 77 years of age, weighting 134.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: colitis ischaemic, rectal haemorrhage. VIDAZA dosage: 75 MG/M2, INTRAVENOUS. During the same period patient was treated with VITAMIN, FERROUS SULPHATE, ESOMEPRAZOLE, OXYCODONE. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5762001-0
VIDAZA problem was reported by a Physician from FRANCE on May 19, 2008. Male patient, 76 years of age, weighting 125.7 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell, lobar pneumonia, no therapeutic response, pleural effusion. VIDAZA dosage: 100 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with FERRIPROX, IMOVANE, LACTEOL, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5762002-2
Physician from FRANCE reported VIDAZA problem on May 20, 2008. Male patient, 50 years of age, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, complications of bone marrow transplant, cytolytic hepatitis, renal failure. VIDAZA dosage: 75 MG/M2, DAILY, SUBCUTANEOUS. During the same period patient was treated with ROVAMYCINE, VALACYCLOVIR, CORTICOSTEROIDS, GRANOCYTE, AUGMENTIN, AMOXICILLIN. Patient recovered.
Vidaza Side Effects Report #5762004-6
VIDAZA problem was reported by a Physician from FRANCE on May 21, 2008. Male patient, 55 years of age, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. VIDAZA dosage: 150 MG, DAILY, X 7, SUBCUTANEOUS. During the same period patient was treated with HYDREA, GLYBURIDE, TENORMIN, PRAVASTATIN, ASPEGIC, OMEPRAZOLE, PREVISCAN. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5766018-1
Physician from UNITED STATES reported VIDAZA problem on May 23, 2008. Female patient, 66 years of age, weighting 187.4 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: breast haematoma, ecchymosis, epistaxis, idiopathic thrombocytopenic purpura, injection site induration, injury, karyotype analysis abnormal, neutropenia, pancytopenia. VIDAZA dosage: (50 MG/M2, DAILY X 10 DAYS), SUBCUTANEOUS. During the same period patient was treated with COMPAZINE, VITAMINS. Patient recovered.
Vidaza Side Effects Report #5767809-3
VIDAZA problem was reported by a Physician from FRANCE on May 26, 2008. Male patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: glycosylated haemoglobin increased, type 1 diabetes mellitus. VIDAZA dosage: (75 MG/M2, DAILY X 7 DAYS) ,SUBCUTANEOUS. During the same period patient was treated with DEPAKENE, VESANOID, FOLIC ACID, ATORVASTATIN CALCIUM, SERENOA REPENS, RAUBASINE DIHYDROERGOCRISTINE, ALLOPURINOL. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5771531-7
Pharmacist from GERMANY reported VIDAZA problem on May 30, 2008. Male patient, 64 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: abscess, injection site necrosis, injection site nodule, injection site vasculitis. VIDAZA dosage: (75 MG/M2), SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5771533-0
VIDAZA problem was reported by a Health Professional from FRANCE on June 02, 2008. Male patient, 55 years of age, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. VIDAZA dosage: (150 MG DAILY X 7), SUBCUTANEOUS. During the same period patient was treated with HYDREA, GLYBURIDE, TENORMIN, PRAVASTATIN, ASPEGIC, OMEPRAZOLE, PREVISCAN. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5777991-X
Physician from UNITED STATES reported VIDAZA problem on June 04, 2008. Female patient, 72 years of age, weighting 123.5 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: bronchopulmonary aspergillosis, condition aggravated, pancytopenia. VIDAZA dosage: 120 MG/M2, DAILY X 7 DAYS, INTRAVENOUS. During the same period patient was treated with LISINOPRIL, FUROSEMIDE, CYCLOSPORINE, CARVEDILOL, PREDNISONE. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5730345-4
VIDAZA problem was reported by a Physician from FRANCE on Apr 24, 2008. Male patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: type 1 diabetes mellitus. VIDAZA dosage: (75 MG/M2, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with DEPAKENE, VESANOID, FOLIC ACID, ATORVASTATIN CALCIUM, SERENOA REPENS, RAUBASINE DIHYDROERGOCRISTINE, ALLOPURINOL. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5738425-4
Physician from UNITED STATES reported VIDAZA problem on Apr 30, 2008. Male patient, 75 years of age, weighting 218.3 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, disease progression, hilar lymphadenopathy, lymphadenopathy mediastinal, pharyngitis streptococcal, prothrombin time prolonged, pulmonary embolism. VIDAZA dosage: 75 MG/M2, DAILY X 5,SUBCUTANEOUS. During the same period patient was treated with OXYCODONE, CARTIA XT, HYDRALAZINE, ANAGRELIDE, LASIX, COUMADIN, POTASSIUM, VITAMIN B12. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5744798-9
VIDAZA problem was reported by a Physician from UNITED STATES on May 02, 2008. Female patient, 77 years of age, weighting 134.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: colitis ischaemic. VIDAZA dosage: 75 MG/M2, INTRAVENOUS. During the same period patient was treated with VITAMIN, FERROUS SULPHATE, ESOMEPRAZOLE, OXYCODONE. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5710716-2
Physician from FRANCE reported VIDAZA problem on Mar 31, 2008. Male patient, 72 years of age, weighting 178.6 lb, was diagnosed with myelodysplastic syndrome, neutropenia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: apnoea, bronchial obstruction, interstitial lung disease, pulmonary fibrosis, pulmonary function test abnormal. VIDAZA dosage: (75 MG/M2,DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with GRANOCYTE, DEPAKENE, VESANOID, SECTRAL, ALLOPURINOL, PANTOPRAZOLE, RENITEC, FORLAX. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5713661-1
VIDAZA problem was reported by a Physician from SWITZERLAND on Apr 03, 2008. Male patient was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: dermatitis, skin ulcer. VIDAZA dosage: 100 MG/M2, DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with VITAMIN B12. Patient recovered.
Vidaza Side Effects Report #5717178-X
Physician from UNITED STATES reported VIDAZA problem on Apr 12, 2008. Male patient, 71 years of age, weighting 227.1 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: anuria, cardiac tamponade, hyperkalaemia, metabolic acidosis, pericarditis, renal failure acute, septic shock, staphylococcal infection. VIDAZA dosage: (75 MG/M2, DAILY X 5 DAYS) INTRAVENOUS. During the same period patient was treated with KYTRIL, ANIDULAFUNGIN, AZITHROMYCIN, FLORINEF, HYDROCORTISONE, INSULIN, MEROPENEM, VANCOMYCIN. Patient was hospitalized. Patient died on 03/15/2008.
Vidaza Side Effects Report #5723350-5
VIDAZA problem was reported by a Physician from SWITZERLAND on Apr 18, 2008. Male patient was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: dermatitis, skin discolouration, skin injury. VIDAZA dosage: (100 MG/M2, DAILY X 5 DAYS), SUBCUTANEOUS, (100 MG/M2, DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with VITAMIN B12. Patient recovered.
Vidaza Side Effects Report #5354898-3
Physician from UNITED STATES reported VIDAZA problem on June 04, 2007. Male patient, 79 years of age, weighting 199.1 lb, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood potassium decreased, crepitations, decreased appetite, discomfort, dyspnoea exertional, fatigue. VIDAZA dosage: 50 MG/M2 (DAYS 1 THROUGH 10, EVERY 28 DAYS), SUBCUTANEOUS. During the same period patient was treated with LASIX, COLACE, SENOKOT, NEURONTIN, PENICILLIN. Patient died on 04/26/2007.
Vidaza Side Effects Report #5367782-6
VIDAZA problem was reported by a Physician from UNITED KINGDOM on June 04, 2007. Male patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: anaemia, haemolysis, nausea, polychromasia, red blood cell spherocytes present. VIDAZA dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE, ACYCLOVIR. Patient recovered.
Vidaza Side Effects Report #5343436-7
Physician from UNITED KINGDOM reported VIDAZA problem on May 17, 2007. Male patient, 55 years of age, weighting 188.7 lb, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: blood culture positive, blood pressure systolic decreased, condition aggravated, neutropenic sepsis, pseudomonas infection, refusal of treatment by patient, sputum culture positive, white blood cell count decreased. VIDAZA dosage: 75 MG/M2 (150 MG ONCE DAILY X FIVE DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROATE, THEOPHYLLINE, ATRA, VALACYCLOVIR, METRONIDAZOLE, ADCORTYL IN ORAL BASE, AMILORIDE. Patient was hospitalized. Patient died on 05/09/2007.
Vidaza Side Effects Report #5293978-8
VIDAZA problem was reported by a Physician from UNITED STATES on Mar 23, 2007. Female patient, 47 years of age, weighting 135.4 lb, was diagnosed with myelodysplastic syndrome, decreased appetite and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: decreased appetite, fungal infection, hepatic infection, lung neoplasm, pulmonary embolism. VIDAZA dosage: 40 MG/M2 (DAYS 1 TO 10, EVERY 28 DAYS), SUBCUTANEOUS. During the same period patient was treated with MEGACE, ATIVAN, VFEND, CASPOFUNGIN. Patient recovered.
Vidaza Side Effects Report #5286019-X
Physician from UNITED STATES reported VIDAZA problem on Mar 16, 2007. Male patient, 79 years of age, weighting 181.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: atelectasis, hypotension, hypoxia, pleural effusion, productive cough, renal failure, sepsis, sputum discoloured, sputum purulent. VIDAZA dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with METFORMIN, ASPIRIN, DOXYCYCLINE, GUAIFENESIN, POTASSIUM. Patient was hospitalized. Patient died on 03/17/2007.
Showing 1-40 of 67 Next >